CCSD code 0504G: YMDD mutation test billing guide

Key Takeaways

CCSD code 0504G is the UK private healthcare code for the YMDD mutation test, a genetic analysis that detects mutations in the YMDD motif (tyrosine-methionine-aspartate-aspartate) of the hepatitis B virus polymerase gene. It sits in Chapter 34.1.3 of the CCSD schedule.

0504G replaced the retired code 8216B. Bill the current code, and confirm its narrative in the authenticated CCSD schedule at ccsd.org.uk or the Bupa code search portal before you submit.

Major UK insurers including Bupa, AXA Health, Aviva, Vitality, and Allianz Care recognise CCSD codes as the billing standard, but pre-authorisation rules and reimbursement rates vary by insurer.

Pabau’s claims management software supports structured documentation and audit-ready record-keeping for UK private healthcare billing workflows.

CCSD code 0504G is the code UK private medical insurers recognise for the YMDD mutation test, a genetic analysis that checks a hepatitis B virus (HBV) sample for mutations in the YMDD motif of the viral polymerase gene. The name comes from the four amino acids the motif encodes: Tyrosine, methionine, aspartate, aspartate.

Mutations here are the leading cause of resistance to lamivudine, an antiviral used to treat chronic hepatitis B, so the test is usually requested when a patient on long-term lamivudine therapy shows signs of virologic breakthrough.

The code sits in Chapter 34.1.3 of the CCSD schedule and replaces the retired code 8216B. This guide covers how to verify the code, document it, and get it paid across the major UK insurers.

CCSD code 0504G: Definition, schedule position, and clinical scope

CCSD code 0504G identifies the YMDD mutation test within the Clinical Coding and Schedule Development (CCSD) schedule, the standard code set used across UK private healthcare for consistent clinical activity coding. It is a diagnostic genetic analysis code, not a surgical procedure code, so it belongs on the diagnostic line of an invoice rather than the procedures line.

The CCSD schedule is updated periodically, so confirm the current narrative for 0504G against the authenticated schedule before you submit. Two details matter most at the point of billing: The code covers genetic analysis for YMDD mutations in HBV, and it replaces the older code 8216B, which should no longer be submitted.

Schedule chapter classification

0504G sits in Chapter 34.1.3 of the CCSD schedule, within the Pathology chapter’s molecular and genetic analysis group (34.1). Practitioners moving from NHS to private practice often meet this diagnostic-schedule structure for the first time and misclassify the submission type as a result.

The practical implication is straightforward. The YMDD mutation test is a genetic analysis charge, so 0504G belongs under the diagnostic section of your invoice, and the fee is for the laboratory analysis itself, not a procedure fee.

Submitting a genetic analysis code under a procedures line, or billing the retired 8216B, is a common source of query letters from payer billing teams.

Who requests CCSD code 0504G and in what clinical settings?

The YMDD mutation test is ordered when a patient with chronic hepatitis B on long-term lamivudine therapy shows a rise in HBV DNA viral load or liver enzymes (ALT) after an initial response to treatment, a pattern known as virologic breakthrough.

In private practice, the request usually comes from a hepatologist, gastroenterologist, or infectious disease consultant, and the analysis is run by a molecular virology or pathology laboratory, with the result reported back to the requesting consultant.

That referral chain is why 0504G rarely appears on an invoice in isolation. It typically follows a consultation and a blood sample, and more than one provider may bill for the same episode of care. Patients on long-term lamivudine therapy are sometimes co-managed by functional medicine practices alongside their hepatology specialist, which adds another provider to track across the same episode.

Where a private GP makes the initial referral into hepatology, GP software that ties the referral, the pathology order, and the invoice to one patient record keeps the episode traceable. Getting the code, the requesting clinician, and the report aligned before submission is what keeps the claim moving.

Documentation requirements for CCSD code 0504G

Insurers routinely audit pathology and genetic-test claims. A claim that cannot be matched to supporting clinical documentation at the point of query will either be delayed or rejected outright. Getting the documentation right before submission, not after a denial, is far more efficient.

The following records are expected for a YMDD mutation test claim across the major UK private medical insurers. Store these in a digital clinical forms system so they can be retrieved quickly on request:

• Clinical indication: the reason the test was clinically necessary, typically a documented rise in HBV DNA or ALT during lamivudine therapy, not a generic request.
• Consent record: written consent from the patient, dated on or before the date of service.
• Laboratory report: a contemporaneous report signed by the responsible clinician, stating the mutation(s) detected in the YMDD motif and the method used.
• Pre-authorisation reference number: where the insurer required prior approval, the authorisation number must appear on the invoice. A claim submitted without this reference will be rejected at triage.
• Referring clinician details: most insurers require the name and GMC number of the requesting practitioner for diagnostic tests.

UK private practices also have obligations under data protection law when storing and handling clinical records. A GDPR compliance checklist for healthcare settings covers the key retention and access requirements your practice needs to maintain alongside billing documentation.

Documentation anti-patterns that trigger audits

Three documentation problems generate the majority of insurer audit letters for diagnostic-test claims:

• A clinical indication that is too vague, such as “routine check,” which does not satisfy medical necessity standards for resistance testing.
• A missing or undated consent record.
• A report that gives only a positive or negative result without naming the specific mutation or the method used.

Each of these can be fixed at the point of care with structured note templates rather than retrospectively.

Insurer-specific rules: Bupa, AXA Health, Aviva, Vitality, and Allianz Care

No two insurers handle CCSD diagnostic claims identically. Fee levels, pre-authorisation thresholds, and invoice format requirements differ. The table below summarises the key policy positions that affect how you submit CCSD code 0504G claims to each major insurer. Always verify current rules directly with each payer, as fee schedules and approval thresholds are updated periodically.

For Bupa specifically, the Bupa CCSD codes guide on Pabau explains how to use the Bupa code search portal to confirm whether a code is covered under a patient’s policy before the appointment. This step alone prevents a significant share of post-service denials.

Bupa CCSD codes: code search and fee confirmation

Bupa uses CCSD as the industry standard for clinical activity coding, and runs its own code search portal so providers can confirm which codes it recognises and at what fee level.

Before billing CCSD code 0504G to Bupa, search the code in the portal to verify it returns a recognised fee. If the code does not appear, contact the Bupa provider helpline before submitting.

AXA Health: Fee chapter alignment

AXA Health organises its codes by fee chapter. When submitting a diagnostic code, confirm which chapter your service falls into via the AXA specialist procedure codes portal. Mismatched chapter assignments are a leading cause of query letters from AXA. Your compliance management tools should flag chapter mismatches before an invoice is finalised.

Vitality: Fee finder and coverage verification

Vitality Health operates a fee finder tool that lets providers look up the benefit amount Vitality will pay for a specific CCSD code under a patient’s policy. Run this check before the consultation to set correct patient expectations about any shortfall. Vitality requires pre-authorisation for most diagnostic tests, and the authorisation reference must appear on the invoice.

Allianz Care: Diagnostic test coverage

The Allianz Care fee schedule sets out the UK codes it recognises and the fees it pays. Confirm that 0504G is listed and covered under the patient’s plan before you submit, as coverage for genetic and virology tests can differ from plan to plan. Where a test is not listed, contact Allianz Care before invoicing rather than assuming the fee.

Pre-authorisation process for CCSD code 0504G

Pre-authorisation is expected for diagnostic and genetic tests with the major UK private medical insurers. Submitting a claim without a valid authorisation number is the fastest route to a rejected invoice. The process varies slightly by insurer but follows the same general sequence across Bupa, AXA Health, Aviva, Vitality, and Allianz Care.

1. Confirm coverage before the appointment. Ask the patient to confirm with their insurer that CCSD code 0504G is covered under their policy. The patient, or the practice on their behalf, obtains a provisional authorisation number and a confirmed benefit amount.
2. Record the authorisation number. Store the pre-authorisation reference in the patient record when it is received. Systems with structured client record management can attach this reference directly to the appointment, making it retrievable at the point of invoicing.
3. Submit the claim with the reference on the invoice. Every invoice line for CCSD code 0504G must carry the authorisation number. Insurers match claims to authorisations at processing, and a missing reference fails the match automatically.
4. Meet the submission deadline. Most major insurers impose a time limit on claim submission after the date of service, typically three to six months. Claims submitted outside this window are rejected regardless of clinical validity.
5. Respond to queries promptly. Insurers may request supporting documentation after an initial submission. Practices using claims management software can track open queries against each claim and set response reminders.

Related CCSD codes and cross-coding considerations

The YMDD mutation test rarely appears in isolation on a claim. It’s typically ordered alongside HBV viral load quantification and other hepatitis monitoring tests as part of the same episode of care. Understanding the codes that commonly accompany CCSD code 0504G prevents both under-coding, which leaves reimbursable items off the invoice, and over-coding, which bills a bundled item twice.

The CCSD Technical Guide sets out the business rules that govern code combinations, so check it for the specific codes you intend to submit together.

The same single-marker logic applies wherever a lab runs more than one genetic marker from the same sample. CCSD codes 0006G and 0022G are both single-marker genetic codes governed by the same combination rules, so the principle of checking business rules before billing multiple markers together applies equally here.

The same logic extends to newer single-marker additions to the schedule. CCSD codes 0037G and 0042G follow the identical combination rules, so confirm the business rules before billing either alongside another genetic marker taken from the same sample.

Practices that regularly bill combinations of hepatitis monitoring codes benefit from a structured review process before submission, supported by medical lab software that ties each result to the correct billing code automatically.

Combination claims carry the same compliance documentation requirements as single-code invoices, including record-keeping obligations for UK private practices.

Common claim errors for CCSD code 0504G

Claims for the YMDD mutation test fail for predictable, preventable reasons. The private healthcare referral pathway adds complexity, because a single episode of care may involve a hepatologist, a molecular pathology laboratory, and separate invoices, and coordination errors compound quickly. These are the most common failure patterns.

1. Missing or invalid pre-authorisation reference

This accounts for a disproportionate share of first-pass rejections. The fix is process-level: Build a check that no invoice is finalised without a recorded authorisation number. Some practices designate a billing coordinator to confirm the reference is present before the invoice leaves the practice.

2. Submitting under the wrong schedule or a retired code

Billing a diagnostic genetic analysis code under the procedures section, or submitting the retired 8216B instead of 0504G, is detected at insurer processing and generates a query.

Practices new to CCSD billing often hit this error on their first few diagnostic invoices, especially those still refining their private practice workflows. The CCSD schedule is the definitive source for the current code and its chapter.

3. Duplicate billing within a hepatitis monitoring panel

When YMDD mutation testing is ordered as part of a broader hepatitis monitoring panel that carries its own code, billing both the panel and 0504G overstates the claim and triggers audit flags.

The reverse error, splitting out a marker that should sit inside a panel, can under-code the claim. Both are avoidable by checking the CCSD business rules for the specific combination before submission.

4. Late submission

Every insurer imposes a submission deadline measured from the date of service, most often three to six months. A claim that is clinically valid and fully documented will still be rejected if it arrives outside the window.

Tracking open invoices against their service dates and deadlines is a core function of a billing workflow. The CQC’s role in governance covers record-keeping standards that apply just as much to billing documentation as to clinical records.

5. Insufficient clinical documentation

A claim that passes initial processing may still be queried at audit if the supporting clinical record is thin. Insurers increasingly request documentation as part of post-payment review programmes. Maintaining a complete, contemporaneous record for every CCSD code 0504G service, stored where it can be retrieved quickly, is the most effective defence against retrospective audit challenges.

How to submit CCSD code 0504G claims via Healthcode

Healthcode is the primary electronic data interchange platform for UK private healthcare claims. Most major insurers, including Bupa, AXA Health, Aviva, Vitality, and Allianz Care, accept electronic submissions via Healthcode. Paper-based submission is still accepted by some insurers but increases processing times and error rates.

A standard Healthcode submission for CCSD code 0504G requires the following data fields to be complete and accurate:

• CCSD code: 0504G, entered exactly as it appears in the CCSD schedule.
• Diagnostic description: the standard CCSD narrative for the code, not a free-text substitute.
• Date of service: matching the clinical record exactly.
• Pre-authorisation number: from the insurer, matching the policy and member details.
• Practitioner details: the GMC number of the requesting clinician.
• Practice code: the insurer-assigned provider number for your practice.
• Fee charged: must not exceed the insurer’s recognised fee for 0504G without prior agreement.

Practices managing a high volume of CCSD claims benefit from integrating their practice management system with Healthcode directly. This removes manual re-keying of data between clinical records and claim submissions, which is where transcription errors most commonly occur.

Moving patient data between a practice system and Healthcode also carries its own GDPR obligations around data transfer, on top of the retention rules covered earlier in this guide.

Continue your research

Billing another single-marker genetic pathology code? 0006G covers KRAS mutation analysis, with its own documentation and bundling rules.

Need a comparable single gene test guide? 0022G covers C-MYC (MYC) gene testing and how it’s billed across UK insurers.

Handling a related molecular diagnostic code? 0029B covers the MLH1 promoter hypermethylation test, with its own pre-authorisation requirements.

Also billing a genomic marker test? 0040G covers MRD genomic sequencing for blood cancers, with its own combination and pre-authorisation rules.

Stop chasing claim rejections

Pabau helps UK private practices submit CCSD-coded invoices accurately, track pre-authorisation status, and respond to insurer queries from one place.

Book a demo

Conclusion

Claim rejections on CCSD code 0504G are rarely caused by the clinical work being wrong. They are caused by process problems: A missing authorisation number, a diagnostic code billed as a procedure, the retired 8216B submitted by mistake, or documentation that cannot support a post-payment audit. Fix the process and the YMDD mutation test claim usually pays on first pass.

Pabau’s claims management software helps UK private practices track authorisation status, attach clinical documentation to each claim, and meet insurer submission deadlines without manual chasing. If your team is spending time correcting avoidable diagnostic-code denials, book a demo to see how Pabau handles the billing workflow end to end.

Frequently asked questions